SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Olney RS. Preventing morbidity and mortality from sickle cell disease: a public health perspective. Am J Prev Med 1999;16:116120.
  • 2
    Consensus Development Panel, NIH, Newborn Screening for Sickle Cell Disease and other Hemoglobinopathies. JAMA 1987;258:12051209.
  • 3
    Ballas SK, Park D, Wapner RJ. Neonatal screening for sickle cell disease in a metropolitan university hospital: efficacy and problems. J Med Screen 1994;1:229232.
  • 4
    Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol 1996;18:3641.
  • 5
    Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986;314:15931599.
  • 6
    Abramson JS, Baker CJ, Fisher MC, et al. American Academy of Pediatrics Committee on Infectious Diseases: Policy Statement: Recommendations for the prevention of pneumococcal infections, including the case of pneumococcal conjugate vaccine (Prevnar) pneumococcal polysaccharide vaccine, and antibiotics prophylaxis. Pediatrics 2000;106:362366.
  • 7
    Embury SH, Hebbel RP, Mohandas N, Steinberg MR. Sickle cell disease. Basic principles and clinical practice. New York: Raven Press; 1994.
  • 8
    Ballas SK. Sickle cell pain. Progress in pain research and management. Vol 11. Seattle, WA: IASP Press; 1998.
  • 9
    Serjeant GR, Serjeant BE. Sickle cell disease. 3rd edition. Oxford, England: Oxford University Press; 2001.
  • 10
    Platt OS, Brambilla DJ, Rosse WF, et al. Mortality and sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330:16341644.
  • 11
    Houston-Yu P, Rana SR, Beyer B, Castro O. Frequent and prolonged hospitalization: a risk factor for early mortality in sickle cell disease patients. Am J Hematol 2003;72:201203.
  • 12
    Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:1116.
  • 13
    Woods K, Karrison T, Koshy M, Patel A, Friedman P, Cassel C. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Publ Health Rep 1997;112:4451.
  • 14
    Ballas SK. Bone marrow transplantation in sickle cell anemia: Why so few so late? Lancet 1992;340:1226.
  • 15
    Bain BJ. Hemoglobinopathy diagnosis. Oxford, England: Blackwell Science; 2001.
  • 16
    Fishman B, Pasternak S, Wallenstein SL, Houde RW, Holland JC, Foley KM. The Memorial Pain Assessment card: a valid instrument for the evaluation of cancer pain. Cancer 1987;60: 11511158.
  • 17
    Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood 2000;95(4):11301136.
  • 18
    Carr DB, Jacox A, Chapman R, et al. Acute pain management: Operative or medical procedures and trauma. Clinical practice guideline. AHCPR publication no. 92–0032. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Services; 1992.
  • 19
    Jacox A, Carr DB, Payne R, et al. Management of cancer pain. Clinical practice guideline no. 9. AHCPR Publication No. 94–0592. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Services; 1994.
  • 20
    Ballas SK, Delengowski A. Pain measurement in hospitalized adults with sickle cell painful episodes. Ann Clin Lab Sci 1993;23:358361.
  • 21
    Wilkinson L. Systat: the system for statistics. Evanston, IL: Systat, Inc.; 1986.
  • 22
    Benjamin LJ, Dampier CD, Jacox A, et al. Guideline for the management of acute and chronic pain in sickle cell disease. Clinical practice guideline no 1. Glenview, IL: American Pain Society; 1999.
  • 23
    University Health System Consortium, Clinical Database. Chicago, IL, 2004, date of access August 26, 2004.
  • 24
    Jacob E, Miaskowski C, Savedra M, Beyer JE, Treadwell M, Styles L. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease. Pain 2003;102:187193.
  • 25
    van Walraven C, Mamdani M, Fang J, Austin PC. Continuity of care and patient outcomes after hospital discharge. J Gen Intern Med 2004;19:624631.
  • 26
    Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003;138:161167.
  • 27
    Udezue E, Girshab AM. Differences between males and females in adult sickle cell pain crisis in Eastern Saudi Arabia. Ann Saudi Med 2004;24:179182.